John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 2,719 shares at $2.45 ($7K) on 2023-07-05, disclosed to the SEC on 2023-07-07.
Scheduled sale ($7k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GTHX | SELL | 2024-01-08 | $36K | — | Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $406K | — | Filing → |